Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nano-Care Deutschland AG is a specialized manufacturer of high-performance nanotechnology coatings based in Germany. Established in 2000 as a spin-off from the Leibniz Institute for New Materials, the company has become a global leader in "liquid glass" (SiO2) technology. Their product portfolio includes advanced antimicrobial coatings, such as Liquid Guard, which are designed to provide permanent surface protection against pathogens in healthcare settings. These technologies are utilized to prevent hospital-acquired infections by creating self-disinfecting surfaces that kill bacteria and viruses upon contact. Beyond healthcare, the company provides functional finishes for textiles, automotive surfaces, and building materials. Nano-Care operates as a B2B partner, offering private-label manufacturing and chemical concentrates to distributors in over 70 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nano-Care Deutschland.